Prognostic factors in primary fallopian tube carcinoma

Gynecologic Oncology

Volumn 53, Issue 3, 1994, Pages 307-313

  Rosen, A C ^a   Reiner, A ^b   Klein, M ^c   Lahousen, M ^d   Graf, A H ^e   Vavra, N ^b   Auerbach, L ^b   Vorbeck, F ^a   Rosen, H R ^f  

^a DANUBE HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c HANUSCH HOSPITAL   (Austria)

^d UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF SALZBURG   (Austria)

^f Boltzmann Institute for Surgical Oncology ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; UTERINE TUBE CARCINOMA;

FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMAN; MITOSIS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SALPINGITIS; SURVIVAL ANALYSIS;

EID: 0028342751     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1006/gyno.1994.1139     Document Type: Article

References (41)

1. Pfleiderer, A. Tumoren der Tube, in Gynäkologische Onkologie (H. G. Bender, Ed.), Thieme, Stuttgart/New York, pp. 220-225 (1984).
2. Hanton, E. M., Malkasian, G. D., Dahlin, D. C., and Pratt, J. Primary carcinoma of the fallopian tube, Am. J. Obstet. Gynecol. 94, 832-839 (1966).
3. Dodson, M. G., Ford, J. H., and Averette, H. E. Ginical aspects of fallopian tube carcinoma, Obstet. Gynecol. 36, 935-939 (1970).
4. Engeler, V., Reinisch, E., and Schreiner, W. E. Das primäre Tub-enkaranom-Eine klinische Studie an 37 Patienten, Geburtsh. Frauenheilkd. 41, 325-329 (1981).
5. Rosen, A. C., Klein, M., Lahousen, M., Graf, A. H., Bartussek, A., and Vavra, N. Das primäre Tubenkarzinom-eine österreichische Multizenterstudie, Geburtsh. Frauenheilkd. 53, 321-325 (1993).
6. Rosen, A.C., Klein, M., Lahousen, M., Graf, A. H., Reiner, A., and Vavra, N. Primary fallopian tube carcinoma in Austria-A retrospective multicenter study, Br. J. Cancer 68, 605-609 (1993).
7. Hu, Cy., Taymor, M.L., and Hertig, A. T. Primary carcinoma of the fallopian tube, Am. J. Obstet. Gynecol. 59, 58-67 (1950).
8. Rosen, H. R., Moroz, C., Reiner, A., Reinerova, M., Stierer, M., Svec, J., Schemper, M., and Jakesz R. Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer, Breast Cancer Res. Treat. 24, 17-26 (1992).
9. Halvorsen, T. B., and Seim, E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer, J. Clin. Pathol. 42(2), 162-166 (1989).
10. Cheng, L., Binder, S. W., Fu, Y. S., and Lewin, K. J. Demonstration of estrogen receptors by monoclonal antibody in for-malin-fixed breast tumors, Lab. Invest. 58, 346-353 (1988).
11. Esteban, J. M., Kandalft, P. L., Metha, P., Odom-Maryon, T. L., Bacus, S., and Battifora H. Improvement of the quantification of estrogen and progesterone receptos in paraffin-embedded tumors by image analysis, Am. J. Clin. Pathol. 99, 32-38 (1993).
12. Reiner, A., Spona, J., and Reiner, G. Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma: Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies, Am. J. Pathol. 125, 443-449 (1986).
13. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
14. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its considerations, Cancer Chemother. Rep. 50, 163-170 (1986).
15. Cox, D. R. Regression models and life tables, J. R. Stat. Soc. B 34, 187-220 (1972).
16. Dixon, W. J., Brown, M. B., Engelman, L., and Jennrich R. I. BMDP statistical software manual, Vol. 1, Univ. of California Press, Berkeley, CA (1990).
17. McMurray, E. H., Jacobs, A. J., Perez, C. A., Camel, H. M., Kao, M. S., and Galakatos, A. Carcinoma of the fallopian tube, Cancer 58, 2070-2075 (1986).
18. Gurney, H., Murphy, D., and Crowther, D. The management of primary fallopian tube carcinoma, Br. J. Obstet. Gynaecol. 97, 822-826 (1990).
19. Morris, M., Gershenson, D. M., Burke, T. W., Kavanagh, J. J., Silva, E. G., and Wharton, J. T. Treatment of fallopian tube carcinoma with cisplatin, doxyrubicin and cyclophosphamide, Obstet. Gynecol. 76, 1020-1023 (1990).
20. Osborne, C. K., Yokmowitz, M. G., Knight, W. A., and Mc Guire, W. L. The value of estrogen and progesterone receptors in the treatment of breast cancer, Cancer 46(Suppl.), 2884-2889 (1980).
21. McGuire, W. L., Clark, G. M., Dressier, L. B., and Owens, M. A. Role of steroid hormone receptors as prognostic factors in primary breast cancer, Natl. Cancer Inst. Monogr. 1, 19-23 (1986).
22. Thorpe, S. M., Rose, C-, Rasmussen, B. B., Muoridsen, H. T., Bayer, T., and Kieding, N. Prognostic value of steroid hormones receptors: Multivariate analysis of systemically untreated patients with node negative primary breast cancer, Cancer Res. 47, 6126-6133 (1987).
23. Martin, J. D., Hahnei, R., Mc Cartney, A. J., and Woodings, T. L. The effect of estrogen receptors status on survival in patients with endometrial cancer, Am. J. Obstet. Gynecol. 147, 322-4 (1983).
24. Iversen, O.E., Skaarland, E., and Utaaker, E. Steroid receptor content in human ovarian tumors: Survival of patients with ovarian carcinoma related to steroid receptor content, Gynecol. Oncol. 23, 65-76 (1986).
25. Sevelda, P., Denison, U-, Schemper, M., Spona, J., Vavra, N., and Salzer, H. Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarain carcinoma, Br. J. Obstet. Gynecol. 97, 706-712 (1990).
26. Baak, J. P., Schlipper, N. W., Wisse-Brekelsmans, Ec., Ceelen, T., Bosman, F. T., van Geuns, H., and Wils, J. The prognostic value of morphometrical features and cellular DNA content in cis-platin-treated late ovarian cancer patients, Br. J. Cancer 57, 503-508 (1988).
27. Quinn, C. M., and Wright, N.A. The usefulness of clinical measurements of cell proliferation in gynecologic cancer, Int. J. Gy-necol. Pathol. 11, 131-143 (1992).
28. Hatschek, T., Grontoft, O., Fagerberg, G., Stal, O., Sullivan, S., Carstensen, J., and Nordenskjod, B. Cytometric and histo pathologic features of tumors dedected in a randomized mammography screening program: Correlation and relative prognostic influence, Breast Cancer Res. Treat. 15(3), 149-160 (1990).
29. Flamm, J. The value of tumor-associated tissue inflammatory reaction in primary superficial bladder cancer, Urol Res. 18(2), 113-117 (1990).
30. Ayhan, A., Altintas, A., Tuncer, Z. S., Kucukali, T., and Yuce, K. Prognostic value of mitotic activity, eosinophilic and inflammatory reaction in stage I cancer of the uterine cervix, Eur. J. Surg. Oncol. 18(3), 264-266 (1992).
31. Creasman, W. T. Prognostic significance of hormone receptors in endometrial cancer, Cancer 71(Suppl 4), 1467-1471 (1993).
32. Harding, M., Cowan, S., Hole, D., Cassidy, L., Kitchener, H., Davis. J., and Leake, R. Estrogen and progesterone receptors in ovarian cancer, Cancer 65, 486-491 (1990).
33. Clark, G. M., Osborne, C. K., and Mc Guire, W. L. Correlation between progesterone receptor and patient characteristics in human breast cancer, J. Clin. Oncol. 102, 1102-1109 (1984).
34. McGuire, W. L., and Clark, G. M. The prognostic role of progesterone receptors in human breast cancer. Management of hormone-responsive tumors. Highlights of symposium held in Monte Carlo September 21, Basel, Int. J. Cancer Res. Treat. Oncol. (1983).
35. Greene, G. L., Fitch, F. W., and Jensen, E. V. Monoclonal antibodies to eosionphilin: Probes for the study of estrogen receptors, Proc. Natl. Acad. Sei. USA 77, 157-161 (1980).
36. Perrot-Appalant, M., Logeât, F., Croyer-Picard, M. T., and Mil-grom, E. Immuonocytochemical study of mammalian progesterone receptor using monoclonal antibodies, Endocrinology 116/4, 1473-1483 (1985).
37. Mac Carty, W. C. Factors which influence longevity in cancer, Ann. Surg. 76, 9 (1922).
38. An, T., Sood, U., Piertuk, T., Cummings, G., Hashimoto, K., and Crissman, J. D. In situ quantitation of inflammatory mono nuclear cells in ductal infiltrating breast carcinoma, Am. J. Pathol. 128, 52 (1987).
39. Heo, D. S., Whiteside, T. L., Johnson, J. T., Chen, K., Bames, E. L., Herberman, R. B. Long-term interleukin 2-dependent growth and cytotoxic activity of tumour-infiltrating lymphocytes from human squamous cell carcinoma of the head and neck, Cancer Res. 47, 6553 (1987).
40. Whitford, P., Mallon, E. A., George, W.D., and Campbell, A. M. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer, Br. J. Cancer 62, 971-975 (1990).
41. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. The origin and function of tumor-associated macrophages, Immunol. Today 13(7), 265-270 (1992).